DNAPrint Genomics logo

DNAPrint Genomics(OTC) DNAG

Market Cap$1.30KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1990)-100%
5 Year+0%
1 Year-99%
1 Month+0%
$0.00
+0.00%
+0.00Today
DNAPrint Genomics last closing stock price
MetricPriceDate
Last closeUSD 0.002026-10-07
DNAPrint Genomics stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-09-28
1 month+0%USD 0.002026-08-25
3 month+0%USD 0.002026-07-02
Year to date+0%USD 0.002025-12-30
1 year-99.11%USD 0.002025-09-25
3 year+0%USD 0.002023-10-04
5 year+0%USD 0.002021-09-23
Since inception-100%USD 0.201990-08-21

DNAPrint Genomics Financials at a Glance

Market Cap

$1.30KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.93M

Net Income (TTM)

-$4.55M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

11.35 (High)

Price

$0.00

Volume

11

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Nov 18, 2024

DNAG News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About DNAPrint Genomics

DNAPrint Genomics, Inc. is a biotechnology company specializing in genetic analysis solutions and services. The company offers a diverse range of products aimed at ancestry tracing, forensic science, and pharmaceutical research.

Products and Services
  • AncestryByDNA for tracing genetic lineage
  • DNAWitness for forensic analysis of crime scene samples
  • GenomeLab SNPstream Genotyping System for high-throughput genotyping
Growth Outlook
  • Expansion into forensic science and genealogical markets is underway
  • Increasing demand for genetic testing solutions globally
  • Potential partnerships with pharmaceutical companies for research applications
Financial Highlights
  • Recent quarterly revenue of 227,562, showing a focus on growth
  • Trailing twelve months (TTM) revenue of 1,405,000, indicating market interest
  • Operating income margin of 7.3% in the latest quarter, reflecting operational efficiency
DNAPrint Genomics operates in a rapidly evolving biotechnology sector, with a focus on innovative genetic analysis solutions. The company's product offerings cater to various markets, including ancestry, forensic science, and pharmaceutical research, positioning it well for future growth. Recent financial data indicates a revenue increase, suggesting a positive trajectory in market demand. The company’s operational efficiency, as evidenced by its operating income margin, further enhances its appeal to potential investors. With a strategic focus on expanding its market presence and product offerings, DNAPrint Genomics presents an intriguing opportunity in the biotechnology landscape.
AI Generated • Sep 17, 2026

Industry

Biotechnology

Headquarters

Sarasota, FL 34243, US

DNAG Financials

Key Financial Metrics (TTM)

Gross Margin

30.99%

Operating Margin

-364.45%

Net Income Margin

-507.54%

Return on Equity

316.59%

Return on Capital

-248.20%

Return on Assets

-120.24%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.30KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.29B

Volume

11

Avg. Volume

16.15K

Financials (TTM)

Gross Profit

$446.37K

Operating Income

$6.31M

EBITDA

-$5.09M

Operating Cash Flow

-$4.14M

Capital Expenditure

-$165.00K

Free Cash Flow

-$4.31M

Cash & ST Invst.

$134.35K

Total Debt

$5.33M

DNAPrint Genomics Performance Analysis

DNAPrint Genomics sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42006-12-31-19.3%
Q12007-03-3133.4%
Q22007-06-30-32.0%
Q32007-09-30-52.3%
DNAPrint Genomics sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42006-12-3110.0%
Q12007-03-31211.1%
Q22007-06-30-130.0%
Q32007-09-30N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2007YOY CHG

Revenue

$227.56K

-65.1%

Gross Profit

-$6.59K

-103.0%

Gross Margin

-2.90%

N/A

Market Cap

$1.30KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$54.17

N/A

Employees

24

N/A

Net Income

-$1.88M

+43.7%

EBITDA

-$1.51M

+31.8%

Quarterly Fundamentals

Name
Q3 2007YOY CHG

Total Cash

$134.35K

+21.3%

Total Debt

$5.33M

-21.0%

Accounts Receivable

$1.43M

+583.8%

Inventory

$289.16K

+47.6%

Long Term Debt

$259.54K

-40.2%

Short Term Debt

$5.07M

-19.7%

Return on Assets

-1.20%

N/A

Return on Invested Capital

2.53%

N/A

Free Cash Flow

-$1.36M

-2.6%

Operating Cash Flow

-$1.36M

-9.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IPAHInterpharm Holdings, Inc.
$0.00+0.00%
LADXLadRx Corporation
$0.01+0.00%
MHTXManhattan Scientifics, Inc.
$0.00+0.00%
AVXTAVAX Technologies, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$34.05+11.08%
BITOProShares Trust - ProShares Bitcoin ETF
$10.77-3.32%
INTCIntel
$106.33-6.01%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$140.94-11.31%

Questions About DNAG

What is the current price of DNAPrint Genomics?

DNAPrint Genomics is trading at $0.00 per share.

What is the 52-week range for DNAPrint Genomics?

Over the past 52 weeks, DNAPrint Genomics has traded between $0.00 and $0.00.

How much debt does DNAPrint Genomics have?

DNAPrint Genomics total debt is unavailable.

How much cash does DNAPrint Genomics have on hand?

DNAPrint Genomics does not have cash on hand data available.

What is DNAPrint Genomics’s dividend yield?

DNAPrint Genomics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.